Trial intelligence / Profile preview

Cisatracurium for facial nerve monitoring during acoustic neuroma surgery

ChiCTR1800014552Phase 4Not yet recruiting

Sponsor
Shanghai Ninth People's Hospital
Start
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of cisatracurium in acoustic neuroma (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Anesthetic dosage and Physical activity. Planned start Feb 2018; status: not yet recruiting.

02

Drugs

cisatracurium
03

Conditions

acoustic neuroma

Beyond the preview

Go deeper on ChiCTR1800014552.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800014552.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call